Impaired health-related quality of life in acute myeloid leukemia survivors: A single-center study

European Journal of Haematology

Volumn 93, Issue 3, 2014, Pages 198-206

  Leunis, Annemieke ^a   Redekop, William K ^a   Uyl de Groot, Carin A ^a   Löwenberg, Bob ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acute myeloid leukemia; EORTC QLQ C30; EQ 5D; Quality of life

Indexed keywords

ADULT; AGED; DYSPNEA; ECONOMICS; EMPLOYMENT; FATIGUE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCOME; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PAIN; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL ISOLATION; SURVIVOR;

ADULT; AGED; DYSPNEA; EMPLOYMENT; FATIGUE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCOME; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PAIN; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL ISOLATION; SURVIVORS;

EID: 84906089562     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12324     Document Type: Article

References (44)

1. Derolf ÅR, Kristinsson SY, Andersson TM, Landgren O, Dickman PW, Björkholm M. Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. Blood 2009;113:3666-72.
2. Pulte D, Gondos A, Brenner H. Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century. Haematologica 2008;93:594-600.
3. Pulte D, Gondos A, Brenner H. Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood 2009;113:1408-11.
4. Revicki DA, Osoba D, Fairclough D, Barofsky I, Berzon R, Leidy NK, Rothman M. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000;9:887-900.
5. Estey EH. Acute myeloid leukemia: 2013 Update on risk-stratification and management. Am J Hematol 2013;88:317-27.
6. Bevans M. Health-related quality of life following allogeneic hematopoietic stem cell transplantation. ASH Educ Prog Book 2010;2010:248-54.
7. Efficace F, Novik A, Vignetti M, Mandelli F, Cleeland CS. Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here? Haematologica 2007;92:1596-8.
8. Efficace F, Kemmler G, Vignetti M, Mandelli F, Molica S, Holzner B. Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - A systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer 2008;44:1497-506.
9. Redaelli A, Stephens JM, Brandt S, Botteman MF, Pashos CL. Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life. Cancer Treat Rev 2004;30:103-17.
10. Messerer D, Engel J, Hasford J, et al.; for the German AML Intergroup. Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Haematologica 2008;93:826-33.
11. Zittoun R, Suciu S, Watson M, et al. Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial. Bone Marrow Transplant 1997;20:307-15.
12. Watson M, Buck G, Wheatley K, Homewood JR, Goldstone AH, Rees JKH, Burnett AK. Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients: analysis of the UK medical research council AML 10 trial. Eur J Cancer 2004;40:971-8.
13. Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol 2005;23:6596-606.
14. Löwenberg B, van Putten W, Theobald M, et al. Dutch-Belgian Hemato-Oncology Cooperative Group, Swiss Group for Clinical Cancer Research. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med 2003;349:743-52.
15. Löwenberg B, Pabst T, Vellenga E, et al. Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) Collaborative Group. Cytarabine dose for acute myeloid leukemia. N Engl J Med 2011;364:1027-36.
16. Löwenberg B, Ossenkoppele GJ, van Putten W, et al. Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON), German AML Study Group (AMLSG), Swiss Group for Clinical Cancer Research (SAKK) Collaborative Group. High-dose daunorubicin in older patients with acute myeloid Leukemia. N Engl J Med 2009;361:1235-48.
17. Ossenkoppele GJ, Stussi G, Maertens J, et al. Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK). Blood 2012;120:4706-11.
18. HOVON: Dutch-Belgian Cooperative Trial Group for Hematology-Oncology. 2011; 2013: Available at http://www.hovon.nl/studies/studies-per-ziektebeeld/aml.html?action=showstudie&studie_id=63&categorie_id=4.
19. Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72.
20. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727-36.
21. Pickard AS, De Leon MC, Kohlmann T, Cella D, Rosenbloom S. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Med Care 2007;45:259-63.
22. van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012;15:708-15.
23. Aaronson NK, Ahmedzai S, Bergman B, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
24. King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996;5:555-67.
25. König HH, Bernert S, Angermeyer MC, et al. ESEMeD/MHEDEA 2000 Investigators. Comparison of population health status in six European countries: results of a representative survey using the EQ-5D questionnaire. Med Care 2009;47:255-61.
26. van de Poll-Franse LV, Mols F, Gundy CM, Creutzberg CL, Nout RA, Verdonck-de Leeuw IM, Taphoorn MJ, Aaronson NK. Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer 2011;47:667-75.
27. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995;273:59-65.
28. Holland JC. History of psycho-oncology: Overcoming attitudinal and conceptual barriers. Psychosom Med 2002;64:206-21.
29. Cocks K, King MT, Velikova G, Fayers PM, Brown JM. Quality, interpretation and presentation of European organisation for research and treatment of cancer quality of life questionnaire core 30 data in randomised controlled trials. Eur J Cancer 2008;44:1793-8.
30. Austin PC, Tu JV. Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial infarction mortality. J Clin Epidemiol 2004;57:1138-46.
31. Daniëls L, Oerlemans S, Krol AG, Poll-Franse L, Creutzberg C. Persisting fatigue in hodgkin lymphoma survivors: a systematic review. Ann Hematol 2013;92:1023-32.
32. Minton O, Stone P. How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature. Breast Cancer Res Treat 2008;112:5-13.
33. Persoon S, Kersten MJ, van der Weiden K, Buffart LM, Nollet F, Brug J, Chinapaw MJM. Effects of exercise in patients treated with stem cell transplantation for a hematologic malignancy: a systematic review and meta-analysis. Cancer Treat Rev 2013;39:682-90.
34. Puetz TW, Herring MP. Differential effects of exercise on cancer-related fatigue during and following treatment: a meta-analysis. Am J Prev Med 2012;43:e1-24.
35. Eom CS, Shin DW, Kim SY, Yang HK, Jo HS, Kweon SS, Kang YS, Kim JH, Cho BL, Park JH. Impact of perceived social support on the mental health and health-related quality of life in cancer patients: results from a nationwide, multicenter survey in South Korea. Psycho-Oncology 2012;22:1283-90.
36. Luszczynska A, Pawlowska I, Cieslak R, Knoll N, Scholz U. Social support and quality of life among lung cancer patients: a systematic review. Psycho-Oncology 2012;22:2160-68.
37. Waters EA, Liu Y, Schootman M, Jeffe DB. Worry about cancer progression and low perceived social support: implications for quality of life among early-stage breast cancer patients. Ann Behav Med 2012;45:57-68.
38. Pidala J, Anasetti C, Jim H. Quality of life after allogeneic hematopoietic cell transplantation. Blood 2009;114:7-19.
39. Cornelissen JJ, Löwenberg B. Role of allogeneic stem cell transplantation in current treatment of acute myeloid leukemia. ASH Educ Prog Book 2005;2005:151-5.
40. Koreth J, Schlenk R, Kopecky KJ, et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 2009;301:2349-61.
41. Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer 2005;104:2565-76.
42. Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 1999;48:1507-15.
43. Sherman AC, Simonton S, Latif U, Plante TG, Anaissie EJ. Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation. Biol Blood Marrow Transplant 2009;15:12-20.
44. Gottlieb BH, Bergen AE. Social support concepts and measures. J Psychosom Res 2010;69:511-20.